The use of amphotericin B in hematologic malignancy children with invasive fungal infections

He Lan,Gao Yijin,Lu Fengjuan,Zhai Xiaowen,Wang Hongsheng,Li Jun

DOI: https://doi.org/10.3969/j.issn.1673-5323.2009.01.005

2009-01-01

Abstract:Objective To evaluate the clinical feathers and safety of Amphotericin B by analyzing the efficacy of Amphotericin B in the treatment of invasive fungal infections in children with hematologic malignancy.Methods Retrospetive review the clinical feathers and anti-fungi therapy of 19 children with fungal infections,to analyze the clinical findings and laboratory results by given Amphotericin B.Results In the 19 cases,four of them were definitely diagnosed to invasive fungal infections,ten of them were clinically diagnosed and five were suspectively diagnosed.Eight of them had fungal infections in respiratory system,one in subcutaneous node, one in conchae nasals,one in liver and spleen,two had septicemia,and one had abscess in pharyngeal wall.Three cases were fully recovered and nine cases got much better after the treatment of Amphotericin B.The overall clinical efficacy rate of Amphotericin B was 66.67%. The main adverse reaction was hepatic impairment and hypokalemia.Conclusions It may be well-tolerated in most children with hematologic malignancy if traditional Amphotericin B is administered properly,and the adverse reation are managed appropriately.